Bionano Genomics (BNGO) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Bionano Genomics (BNGO) is Moderate Underperform.

The composite score behind that read is -0.21, weighing +0.00 of bullish evidence against -0.50 bearish.

Bionano Genomics last closed at $1.44, -1.37% on the session.

Against the IVW growth benchmark the position is -2.17% over the forecast window.

The read is built from 15 underlying insights — 0 bullish and 15 bearish.

Agreement across those insights is 100%.

20 graded predictions for BNGO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Bionano Genomics in the 13th percentile on return on equity, where 100 is best.

Bionano Genomics is classified under Health Care / Life Sciences Tools & Services, with a market capitalisation of $17.19M.

StockMap tracks Bionano Genomics as the 41st largest of the 41 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 37 Neutral, 2 Moderate Outperform and 2 Moderate Underperform.

On that composite Bionano Genomics ranks 40th of 41 in the group, against a group median of +0.06.